Article Information
History
- April 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Narendra Chirmule1,*,
- Pradip Nair2,
- Bela Desai3,
- Ravindra Khare1,
- Vivek Nerurkar4 and
- Amitabh Gaur5,*
- 1SymphonyTech Biologics, Philadelphia, Pennsylvania, USA
- 2Biocon, Bangalore, Karnataka, India
- 3NanoCellect Biomedical, Inc., San Diego, California, USA
- 4Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA
- 5Innovative Assay Solutions LLC, San Diego, California, USA
- ↵*Address Correspondence to: Narendra Chirmule at Narendra.Chirmule{at}symphonytech.com or Amitabh Gaur at agaursd{at}gmail.com
Posted April 07, 2021.
Predicting the severity of disease progression in COVID-19 at the individual and population level: A mathematical model
